1 hr 3 min

Corticosteroids for Bronchiolitis? - A Conversation with an Intensivist PHM from Pittsburgh

    • Medicine

Activity Title: Pediatric Hospital Medicine: Corticosteroids in Bronchiolitis? A Conversation with an Intensivist
 
Target Audience
This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.
 
Objectives:
Upon completion of this activity, participants should be able to:
•Describe how the PICU will use steroids for bronchiolitis.
•Recognize why the PICU will use steroids for bronchiolitis.
•Evaluate the evidence for and against steroids for bronchiolitis
 
Faculty: 
Planning Committee:
Maha Kaissi, MD, MHPE — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh
 
Course Directors:
Tony R. Tarchichi MD — Assistant Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Diagnostic Referral Group
Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp
 
Jonathan Pelletier, MD — Assistant Professor of Pediatrics at Northeast Ohio Medical University, Akron Children's Hospital
 
Conflict of Interest Disclosure:
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
 
Accreditation Statement:
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
 
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
 
Disclaimer Statement:
The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
 
Released 06/05/2023,  Expires 06/05/2026
 
The direct link to the course (EM_113176) is provided below:
https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=24414&dev=true

Activity Title: Pediatric Hospital Medicine: Corticosteroids in Bronchiolitis? A Conversation with an Intensivist
 
Target Audience
This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.
 
Objectives:
Upon completion of this activity, participants should be able to:
•Describe how the PICU will use steroids for bronchiolitis.
•Recognize why the PICU will use steroids for bronchiolitis.
•Evaluate the evidence for and against steroids for bronchiolitis
 
Faculty: 
Planning Committee:
Maha Kaissi, MD, MHPE — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh
 
Course Directors:
Tony R. Tarchichi MD — Assistant Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Diagnostic Referral Group
Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp
 
Jonathan Pelletier, MD — Assistant Professor of Pediatrics at Northeast Ohio Medical University, Akron Children's Hospital
 
Conflict of Interest Disclosure:
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
 
Accreditation Statement:
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
 
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
 
Disclaimer Statement:
The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
 
Released 06/05/2023,  Expires 06/05/2026
 
The direct link to the course (EM_113176) is provided below:
https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=24414&dev=true

1 hr 3 min